The trademark application angios biotech was filed by Angios GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on July 25, 2021, and it was registered by office on November 1, 2021 without any oppositions.
The application was filed in German (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical drugs
Medicines for human purposes
Medicine
Biotechnological preparations for medical use
Medicinal preparations and substances
Pharmaceutical preparations for treating diabetes
Pharmaceuticals
Pharmaceutical preparations
Pharmaceutical preparations for the prevention of diabetes.
The mark was filed in class 42 with following description of goods:
Provision of information relating to technological research
Advisory services relating to technological research
Research laboratories
Blood analysis services
Research and development in the field of biotechnology
Laboratory services
Technological services
Scientific laboratory services
Scientific research for medical purposes
Research relating to biotechnology
Biomedical research services
Drug discovery services
Pharmaceutical drug development services
Research and development of vaccines and medicines.
The mark was filed in class 44 with following description of goods:
Medical testing services relating to the diagnosis and treatment of disease
Medical analysis services relating to the treatment of persons provided by a medical laboratory
Medical services in the field of diabetes
Medical testing for diagnostic or treatment purposes